Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1302775
                    [Title] => Drug for blood clot-related conditions approved in Phl
                    [Summary] => 
A breakthrough drug in treating life-threatening post-orthopaedic venous thromboembolism (VTE) has been made available in the Philippines, following the recent approval of Pfizer’s treatment, which is reported to reduce the risk of complications after surgery in adults.

                    [DatePublished] => 2014-03-20 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 759284
                    [Title] => Study supports air travel/VTE link
                    [Summary] => 
Air travel can put frequent or casual flyers at significantly increased for a venous thromboembolic event for up to a month after the end of a trip, British researchers reported at a meeting of the International Society on Thrombosis and Haemostasis.
                    [DatePublished] => 2011-12-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 459852
                    [Title] => Statin reduces life-threatening leg vein clots
                    [Summary] => 
MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.
                    [DatePublished] => 2009-04-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

VTE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1302775
                    [Title] => Drug for blood clot-related conditions approved in Phl
                    [Summary] => 
A breakthrough drug in treating life-threatening post-orthopaedic venous thromboembolism (VTE) has been made available in the Philippines, following the recent approval of Pfizer’s treatment, which is reported to reduce the risk of complications after surgery in adults.

                    [DatePublished] => 2014-03-20 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 759284
                    [Title] => Study supports air travel/VTE link
                    [Summary] => 
Air travel can put frequent or casual flyers at significantly increased for a venous thromboembolic event for up to a month after the end of a trip, British researchers reported at a meeting of the International Society on Thrombosis and Haemostasis.
                    [DatePublished] => 2011-12-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 459852
                    [Title] => Statin reduces life-threatening leg vein clots
                    [Summary] => 
MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.
                    [DatePublished] => 2009-04-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Drug for blood clot-related conditions approved in Phl

March 20, 2014 - 12:00am

A breakthrough drug in treating life-threatening post-orthopaedic venous thromboembolism (VTE) has been made available in the Philippines, following the recent approval of Pfizer’s treatment, which is reported...

Science and Environment

Study supports air travel/VTE link

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 18, 2011 - 12:00am

Air travel can put frequent or casual flyers at significantly increased for a venous thromboembolic event for up to a month after the end of a trip, British researchers reported at a meeting of the International...

Opinion

Statin reduces life-threatening leg vein clots

April 23, 2009 - 12:00am

MANILA, Philippines - New findings from a landmark study revealed that the cholesterol-lowering drug rosuvastatin cuts the risk of venous thromboembolism (VTE) by 43 percent.

Science and Environment